PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
15-Mar-2022 Animal health company Emollivet raises capital and strengthens team Emollivet
15-Mar-2022 Santhera and ReveraGen to Present Efficacy and Safety Data with Vamorolone at 2022 Muscular Dystrophy Association Conference Santhera Pharmaceuticals
15-Mar-2022 Almirall announces a collaboration with the University of Michigan to gain understanding of disease drivers in hidradenitis suppurativa Almirall
15-Mar-2022 BioMed X Institute and Merck KGaA, Darmstadt, Germany, Start Second Research Project in Immunology BioMed X
15-Mar-2022 Biocomposites to present data on STIMULAN® at American Academy of Orthopaedic Surgeons Annual Meeting Biocomposites
15-Mar-2022 2022 PM Society Awards – Winners Announced PM Society
15-Mar-2022 BioInnovation Institute announces latest cohort of companies entering Venture Lab program BioInnovation Institute (BII)
15-Mar-2022 Gadeta announces significant progress in advancing pipeline and TEG platform development Gadeta B.V.
15-Mar-2022 Sanofi announces €300 million collaboration with Blackstone Life Sciences to advance an innovative treatment for multiple myeloma Sanofi
15-Mar-2022 APPLYING FUNDAMENTAL CONCEPTS OF ANTIMICROBIAL STEWARDSHIP IN ERA OF COVID-19 Accelerate Diagnostics, Inc.
15-Mar-2022 Moderna Announces First Participant Dosed In Phase 1 Study Of Its HIV Trimer mRNA Vaccine Moderna
15-Mar-2022 F-star Therapeutics Reports Full-Year 2021 Financial Results and Provides Corporate Update F-star Therapeutics
15-Mar-2022 Dante Labs unveils Dante Genomics, the Company’s B2B global online marketplace delivering genomic solutions for medical professionals, researchers and pharma Dante Labs
15-Mar-2022 Adrenomed Supervisory Board appoints Dr. Richard Jones as CEO Adrenomed AG
15-Mar-2022 BioMed X Institute and Merck KGaA, Darmstadt, Germany, Start Second Research Project in Immunology B3C newswire
15-Mar-2022 ProteoGenix Launches New XtenCHO Transient CHO Expression System to Improve Biologics Development Sciad Newswire
15-Mar-2022 PharmaSGP achieves record results in 2021 - Adjusted EBITDA in Q4 up fivefold year-on-year PharmaSGP Holding SE
15-Mar-2022 APONTIS PHARMA AG: Notice according to Article 2 paragraph 1 of Delegated Regulation (EU) 2016/1052 APONTIS PHARMA AG
15-Mar-2022 Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research Signs an Agreement To Acquire Rights to Commercialize a Novel Dosage Form for the Treatment of PKU Relief Therapeutics Holding SA
15-Mar-2022 PolyPeptide achieves strong profitable growth in 2021 PolyPeptide Group